Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ZADITEN | 1MG | TABLET | Resolved | 2022-12-08 | 2023-04-15 | 177535 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2022-12-15 | 2023-02-16 | 178518 |
ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-12-15 | 2023-04-28 | 178521 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-12-15 | 2023-07-06 | 178530 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179183 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179188 |
TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179194 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179291 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179294 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179300 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179306 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-12-22 | 2023-01-26 | 179309 |
TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-01-12 | 2023-06-09 | 180878 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-01-12 | 2023-01-19 | 180881 |
TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180894 |
TEVA-ALPRAZOLAM | 0.5MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180897 |
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-01-12 | 2023-10-05 | 180900 |
TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-01-12 | 2023-02-16 | 180903 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-01-12 | 2023-07-12 | 180912 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |